US2017050006A1PendingUtilityA1

System for marking a location for treatment within the gastrointestinal tract

62
Assignee: ENTRACK INCPriority: Jun 26, 2001Filed: Sep 1, 2016Published: Feb 23, 2017
Est. expiryJun 26, 2021(expired)· nominal 20-yr term from priority
A61B 5/11A61B 5/065A61B 5/002A61B 5/0084A61B 5/073A61B 18/14A61M 5/1723A61B 5/061A61M 5/172A61N 1/36007A61M 31/002A61B 5/01A61B 2018/00482A61B 2562/162A61B 5/036A61B 5/4839A61B 5/14539A61B 5/6873A61B 5/14503A61B 5/1459A61B 1/00082A61B 2018/00821A61B 1/00016A61B 5/06A61B 2018/00642A61B 1/041A61B 5/4255A61B 5/6801A61B 5/42A61B 5/0538A61N 1/37205A61B 5/4233A61B 2018/00702A61B 2018/00577
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A device and method for mapping, diagnosing and treating the intestinal tract is provided using a capsule passing through the intestinal tract. Further, a capsule tracking system is provided for tracking a capsule's location along the length of an intestinal tract as various treatment and/or sensing modalities are employed. In one variation, an acoustic signal is used to determine the location of the capsule. A map of sensed information may be derived from the pass of a capsule. Capsules may be subsequently passed through to treat the intestinal tract at a determined location along its length. One variation uses an electrical stimulation capsule to treat and/or diagnose a condition in the intestinal tract.

Claims

exact text as granted — not AI-modified
1 . A system for the controlled delivery of a drug to a selected position in the gastrointestinal tract of a patient, the system comprising:
 a capsule sized to pass through an intestinal tract of a patient;   a transmitter coupled to the capsule, the transmitter configured to transmit a tracking signal between the capsule and a location external to a patient's body to track a position of the capsule within the patient's intestinal tract as the capsule is passing through the intestinal tract;   a drug delivery device configured to deliver the drug to the intestinal tract of the patient in response to an actuation signal; and   a controller configured to generate the actuation signal to actuate the drug delivery device as the capsule is passing through the intestinal tract at a desired position in the intestinal tract based on the capsule position within the intestinal tract.   
     
     
         2 . The system of  claim 1  wherein the drug delivery device comprises a pump. 
     
     
         3 . The system of  claim 1 , wherein the drug delivery device comprises a valve or a solenoid. 
     
     
         4 . The system of  claim 1 , wherein the controller is actuable responsive to an external signal. 
     
     
         5 . The system of  claim 4 , wherein the drug delivery device includes an RF receiver for receiving the external signal, the RF receiver operably coupled to at least one of the controller or the drug delivery device. 
     
     
         6 . The system of  claim 4 , wherein the controller actuates the drug delivery device responsive to the external signal. 
     
     
         7 . The system of  claim 6 , wherein the controller includes programming for actuating the drug delivery device responsive to the external signal. 
     
     
         8 . The system of  claim 1 , further comprising:
 a sensor for sensing a condition of the intestinal tract, the sensor operably coupled to at least one of the controller or the drug delivery device.   
     
     
         9 . The system of  claim 8 , wherein the sensor comprises a pressure sensor, a strain gauge or a pH sensor. 
     
     
         10 . The system of  claim 8 , wherein the drug delivery device is actuatable responsive to the sensed condition of the intestinal tract. 
     
     
         11 . The system of  claim 10 , wherein the controller actuates the drug delivery device responsive to the sensed condition of the intestinal tract. 
     
     
         12 . The system of  claim 11 , wherein the controller includes programming for actuating the drug delivery device responsive to the sensed condition. 
     
     
         13 . The system of  claim 1 , wherein the capsule includes the drug. 
     
     
         14 . The system of  claim 1 , further comprising:
 a plurality of transducers configured to receive the tracking signal.   
     
     
         15 . The system of  claim 14 , wherein the plurality of transducers comprises at least three transducers. 
     
     
         16 . The system of  claim 14 , wherein the plurality of transducers are acoustic transducers and the tracking signal is an acoustic tracking signal. 
     
     
         17 . The system of  claim 14 , wherein the plurality of transducers are configured to receive and transmit signals between each other. 
     
     
         18 . The system of  claim 14 , wherein the plurality of transducers are adhereably positioned on the patient's skin. 
     
     
         19 . The system of  claim 14 , wherein at least one of the plurality of transducers also includes an RF device for receiving and/or sending signals to the capsule. 
     
     
         20 . The system of  claim 14 , further comprising:
 a patient wearable recorder device coupled to the plurality of transducers, the recorder device configured to record output from the plurality of transducers.   
     
     
         21 . The system of  claim 1 , further comprising means for identifying a time of tracking signal origination; 
     
     
         22 . The system of  claim 21 , wherein the means for identifying a time of tracking signal origination comprises a reference signal generator coupled to the capsule, the reference signal generator configured to generate and transmit a reference signal for identifying a time of tracking signal origination.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.